Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CK Life Sciences International (Holdings), Inc. ( (HK:0775) ) has shared an announcement.
CK Life Sciences International (Holdings) Inc. has called its 2026 annual general meeting as a hybrid event to be held in Hong Kong and online on 21 May 2026, with a contingency date set for 27 May in case of severe weather. Shareholders will receive the 2025 audited financial statements, elect directors, and appoint the auditor with authority for the board to set the auditor’s remuneration.
The board is also seeking shareholder approval for a revised fee structure for directors and committee members, effective from the 2026 financial year, and a general mandate to issue up to 10% additional share capital at a limited discount to the market benchmark price. These resolutions, if passed, will give the company greater flexibility in capital management and governance, potentially supporting future financing activities and aligning director and committee compensation with their responsibilities.
More about CK Life Sciences International (Holdings), Inc.
CK Life Sciences International (Holdings) Inc., incorporated in the Cayman Islands and listed in Hong Kong, operates in the life sciences sector. The company focuses on health-related technologies and products, serving regional and international markets through its positioning on the Hong Kong Stock Exchange under stock code 0775.
Average Trading Volume: 7,304,885
Technical Sentiment Signal: Buy
Current Market Cap: HK$7.02B
See more insights into 0775 stock on TipRanks’ Stock Analysis page.